- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 307/32 - Atomes d'oxygène
Détention brevets de la classe C07D 307/32
Brevets de cette classe: 112
Historique des publications depuis 10 ans
|
7
|
8
|
10
|
3
|
7
|
12
|
2
|
14
|
6
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| DSM IP Assets B.V. | 5422 |
6 |
| Midwestern University | 42 |
5 |
| Bayer AG | 3470 |
4 |
| Enanta Pharmaceuticals, Inc. | 433 |
4 |
| BASF SE | 21165 |
3 |
| Wisconsin Alumni Research Foundation | 3915 |
3 |
| CJ Cheiljedang Corporation | 3600 |
3 |
| Enzychem Lifesciences Corporation | 61 |
3 |
| Korea Research Institute of Chemical Technology | 1458 |
3 |
| Memorial Sloan-Kettering Cancer Center | 2013 |
3 |
| Boehringer Ingelheim International GmbH | 4494 |
2 |
| Syngenta Participations AG | 1568 |
2 |
| FUJIFILM Corporation | 30327 |
2 |
| JSR Corporation | 2530 |
2 |
| Vertex Pharmaceuticals Incorporated | 1589 |
2 |
| Alphora Research Inc. | 25 |
2 |
| BP Corporation North America Inc. | 742 |
2 |
| Rhode Island Hospital | 202 |
2 |
| Temple University of the Commonwealth System of Higher Education | 634 |
2 |
| V. Mane Fils | 174 |
2 |
| Autres propriétaires | 55 |